Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- None.
- None.
About Alkermes plc
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025512.html
SOURCE Alkermes plc
FAQ
When will the presentation by Alkermes plc CEO Richard Pops take place?
Where can the live webcast of the presentation be accessed?